John Ingraham

John Ingraham has a strong background in machine learning, with experience in both industry and academia. John is currently working as the Head of Machine Learning at Generate Biomedicines, Inc., a position they have held since March 2022. Prior to this role, they served as the Principal Scientist and Senior Scientist of Machine Learning at the same company between 2019 and 2021.

Before their industry experience, John was a Postdoc at the Massachusetts Institute of Technology from October 2018 to September 2019, where they focused on developing machine learning methods for pharmaceutical discovery and synthesis. John also completed their PhD in Systems Biology at Harvard Medical School, where they worked from August 2012 to August 2018.

In addition, John gained valuable research experience during their undergraduate years at Arizona State University and Harvard Medical School. At ASU, they worked on projects related to glioblastoma growth and infiltration as an Undergraduate Researcher in Applied Math and Microbiology. John also conducted research in Systems Biology at Harvard Medical School, where they contributed to a project on genetic differences and cellular signaling pathways.

Overall, John Ingraham has a diverse and extensive background in machine learning and biomedical research, making him a valuable asset in the field.

John Ingraham holds a Doctor of Philosophy (Ph.D.) degree in Systems Biology from Harvard University, which they earned from 2012 to 2018. Prior to that, they completed their undergraduate studies at Arizona State University, obtaining a Bachelor of Science (B.S.) degree in Computational Mathematical Sciences and Biochemistry from 2008 to 2012.